Research Papers:

The ovarian cancer oncobiome

Sagarika Banerjee, Tian Tian, Zhi Wei, Natalie Shih, Michael D Feldman, George Coukos, James C. Alwine, Erle S. Robertson _

Metrics: PDF 166 views  |   HTML 59 views  |   ?  


Sagarika Banerjee1, Tian Tian2, Zhi Wei2, NatalieShih3, Michael D. Feldman3, George Coukos4, James C. Alwine5, Erle S. Robertson1

1Departments of Otorhinolaryngology-Head and Neck surgery, and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States of America

2Department of Computer Science, New Jersey Institute of Technology, New Jersey 07102, United States of America

3Department of Pathology and Laboratory Medicine, University of Pennsylvania 19104, Philadelphia, Pennsylvania, United States of America

4Ludwig Institute for Cancer Research, University of Lausanne Branch and Department of Oncology, CHUV, Lausanne, Switzerland

5Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States of America

Correspondence to:

Erle S. Robertson, email: erle@mail.med.upenn.edu

Keywords: oncobiome, microbiome, ovarian cancer, pathochip, next generation sequencing

Received: August 15, 2016     Accepted: March 08, 2017     Published: March 30, 2017


Humans and other mammals are colonized by microbial agents across the kingdom which can represent a unique microbiome pattern. Dysbiosis of the microbiome has been associated with pathology including cancer. We have identified a microbiome signature unique to ovarian cancers, one of the most lethal malignancies of the female reproductive system, primarily because of its asymptomatic nature during the early stages in development. We screened ovarian cancer samples along with matched, and non-matched control samples using our pan-pathogen array (PathoChip), combined with capture-next generation sequencing. The results show a distinct group of viral, bacterial, fungal and parasitic signatures of high significance in ovarian cases. Further analysis shows specific viral integration sites within the host genome of tumor samples, which may contribute to the carcinogenic process. The ovarian cancer microbiome signature provides insights for the development of targeted therapeutics against ovarian cancers.

Author Information

Sagarika Banerjee

Tian Tian

Zhi Wei

Natalie Shih

Michael D Feldman

George Coukos

James C. Alwine

Erle S. Robertson
Primary Contact  _

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 16717